×
News Home

Evolus Inc (EOLS) is down -0.80% in a Week, Should You Sell?

Thursday, April 07, 2022 03:27 PM | InvestorsObserver Analysts
Evolus Inc (EOLS) is down -0.80% in a Week, Should You Sell?

A rating of 94 puts Evolus Inc (EOLS) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Evolus Inc's score of 94 means it scores higher than 94% of stocks in the industry. Evolus Inc also received an overall rating of 62, putting it above 62% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out of the 148 industries.

Overall Score - 62
EOLS has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on EOLS!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Evolus Inc Stock Today?

Evolus Inc (EOLS) stock is lower by -4.46% while the S&P 500 is up 0.64% as of 3:25 PM on Thursday, Apr 7. EOLS has fallen -$0.52 from the previous closing price of $11.65 on volume of 299,388 shares. Over the past year the S&P 500 is higher by 10.53% while EOLS has fallen -20.10%. EOLS lost -$0.94 per share the over the last 12 months. Click Here to get the full Stock Report for Evolus Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App